Accelerated Identification of Cell Active KRAS Inhibitory Macrocyclic Peptides using Mixture Libraries and Automated Ligand Identification System (ALIS) Technology.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
14 07 2022
Historique:
pubmed: 17 6 2022
medline: 16 7 2022
entrez: 16 6 2022
Statut: ppublish

Résumé

Macrocyclic peptides can disrupt previously intractable protein-protein interactions (PPIs) relevant to oncology targets such as KRAS. Early hits often lack cellular activity and require meticulous improvement of affinity, permeability, and metabolic stability to become viable leads. We have validated the use of the Automated Ligand Identification System (ALIS) to screen oncogenic KRAS

Identifiants

pubmed: 35707970
doi: 10.1021/acs.jmedchem.2c00154
pmc: PMC9289880
doi:

Substances chimiques

Ligands 0
Peptide Library 0
Peptides 0
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8961-8974

Références

J Med Chem. 2020 Jul 9;63(13):6679-6693
pubmed: 32250617
Bioorg Med Chem Lett. 2017 Jun 15;27(12):2757-2761
pubmed: 28457754
Nature. 2018 May;557(7704):228-232
pubmed: 29686415
RSC Med Chem. 2020 Jun 1;11(7):760-770
pubmed: 33479673
Nat Chem Biol. 2019 Apr;15(4):410-418
pubmed: 30886434
J Am Chem Soc. 2019 Mar 13;141(10):4167-4181
pubmed: 30768253
Cell. 2017 Jun 29;170(1):17-33
pubmed: 28666118
ACS Chem Biol. 2021 Feb 19;16(2):293-309
pubmed: 33539064
Cell Discov. 2022 Jan 25;8(1):5
pubmed: 35075146
Biochem Biophys Res Commun. 2017 Mar 11;484(3):605-611
pubmed: 28153726
Science. 2017 Mar 17;355(6330):1158-1163
pubmed: 28302824
J Med Chem. 2022 Feb 24;65(4):3123-3133
pubmed: 34889605
Biochem J. 2017 Mar 15;474(7):1109-1125
pubmed: 28298556
Methods. 2019 Sep 1;167:28-38
pubmed: 31059829
J Am Chem Soc. 2004 Dec 1;126(47):15495-503
pubmed: 15563178
J Med Chem. 2021 Sep 9;64(17):13038-13053
pubmed: 34415745
Anal Biochem. 2004 Jan 15;324(2):241-9
pubmed: 14690688
Sci Rep. 2020 Dec 10;10(1):21671
pubmed: 33303890
Nat Rev Drug Discov. 2014 Nov;13(11):828-51
pubmed: 25323927
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):
pubmed: 28778966
Curr Opin Chem Biol. 2007 Oct;11(5):518-26
pubmed: 17931956
ACS Cent Sci. 2020 Oct 28;6(10):1753-1761
pubmed: 33145412
Anal Biochem. 1998 Apr 10;258(1):19-30
pubmed: 9527843
Nature. 2019 Nov;575(7781):217-223
pubmed: 31666701
Int J Pept Protein Res. 1990 Feb;35(2):141-6
pubmed: 2323887
J Med Chem. 2021 Dec 9;64(23):17287-17303
pubmed: 34787423
J Med Chem. 2014 Nov 13;57(21):8817-26
pubmed: 25313996
Chem Sci. 2021 Nov 25;12(48):15975-15987
pubmed: 35024121
ACS Med Chem Lett. 2017 May 10;8(7):732-736
pubmed: 28740607
Nature. 2013 Nov 28;503(7477):548-51
pubmed: 24256730
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4505-9
pubmed: 1584783
Nat Rev Drug Discov. 2019 Nov;18(12):887-891
pubmed: 31780856
J Med Chem. 2016 Mar 10;59(5):1818-29
pubmed: 26871940
J Cell Sci. 2016 Apr 1;129(7):1287-92
pubmed: 26985062

Auteurs

Michael Garrigou (M)

Merck & Co., Inc., Boston, Massachusetts 02115, United States.

Bérengère Sauvagnat (B)

Merck & Co., Inc., Boston, Massachusetts 02115, United States.

Ruchia Duggal (R)

Merck & Co., Inc., Boston, Massachusetts 02115, United States.

Nicole Boo (N)

MSD International, Singapore 138665, Singapore.

Pooja Gopal (P)

MSD International, Singapore 138665, Singapore.

Jennifer M Johnston (JM)

Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.

Anthony Partridge (A)

MSD International, Singapore 138665, Singapore.

Tomi Sawyer (T)

Merck & Co., Inc., Boston, Massachusetts 02115, United States.

Kaustav Biswas (K)

Merck & Co., Inc., Boston, Massachusetts 02115, United States.

Nicolas Boyer (N)

Merck & Co., Inc., Boston, Massachusetts 02115, United States.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

High mitochondrial DNA levels accelerate lung adenocarcinoma progression.

Mara Mennuni, Stephen E Wilkie, Pauline Michon et al.
1.00
DNA, Mitochondrial Animals Adenocarcinoma of Lung Disease Progression Mice
Animals Huntington Disease Mitochondria Neurons Mice

Classifications MeSH